SEC Form 4 · accession 0001209191-19-005242
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan M Kanaya
Officer — EVP, CFO and Sec.
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 6:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 22, 2019 | M | 37,893 | $3.57 | A | 110,746 | D | |
| Common Stock | Jan 22, 2019 | S | 37,893 | $12.08 | D | 72,853 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $3.57 | Jan 22, 2019 | M | 37,893 | D | — | Mar 7, 2026 | Common Stock | 37,893 | 145,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a March 2018 Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of January 22, 2019, and prior to this transaction, the exercised options were fully vested.
- F3Not applicable.